News

AstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor
AstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - The UK is ‘a hostile environment’ for ...
An AstraZeneca Exit Wouldn’t Doom London
One, it makes sense for AstraZeneca Plc to move its main listing to New York, and two, such a terrible symbolic blow for the ...
COVID-19 Vaccine Induced Rare Blood Clotting Syndrome Explained
Analysis from the Thrombotic Thrombocytopenia Syndrome Consortium has provided critical insights into the rare but serious ...
LondonLovesBusiness12d
Reeves hit with another blow as AstraZeneca considering leaving the UK
The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...
Summit, AstraZeneca (AZN) in Advanced Talks Over $15 billion Oncology Licensing Deal
AstraZeneca PLC (NASDAQ:AZN) is one of the best high growth stocks. Bloomberg reported on July 3 that AstraZeneca is engaged ...
Rediff.com13d
Siddaramaiah Flags Vaccine-Heart Link
Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a ...
AstraZeneca may quit London stock market
The London Stock Exchange has been battling to keep hold of companies and Julia Hoggett, the chief executive of the exchange, ...
Vaccine rollout
More than 450,000 extra Queenslanders will be eligible to receive the Pfizer vaccine after a change to the advice around AstraZeneca, with the Health Minister warning of possible delays as the rollout ...